Home Tags Ophthalmology and Vision
Tag: Ophthalmology and Vision
eNewsChannels NEWS: -- EyeBuyDirect, the fastest growing online retailer of prescription glasses, today released new festive colors for three of their most popular frames, just in time for the holiday season. These new colors will be in a very limited stock and only available from December 3-7, or until they sell out.
eNewsChannels NEWS: -- A recent survey of over 1,000 individuals conducted by EyeBuyDirect, the fastest growing online prescription eyewear retailer, found 4 in 5 people spend five or more hours a day looking at a screen, with a third in front of a screen for eight hours or more. The company recently introduced SightRelax(TM), a new line of digital-protection lenses with the blue-light filter, scratch-resistant and anti-glare coatings, and UV protection.
eNewsChannels NEWS: -- EyeBuyDirect today announced a new line of RFLKT glasses designed with the winter months in the forefront. New styles released include Planete, Illusion, Resonance, Luminous and Era, and will be available starting November 12, 2018. The five new frames in EyeBuyDirect's premium line reflect the best winter has to offer when it comes to colors - clear blue, pink golden and brown striped.
eNewsChannels NEWS: -- Answer and control phone calls, text via voice, listen to music, receive notifications and access WhatsApp without the need to take your smartphone out of your pocket, and still be able to hear the world around you. Say hello to Lucyd Loud, the latest technology in smart eyeglasses.
eNewsChannels NEWS: -- At the beach or by the pool, EyeBuyDirect's new Catch of the Day summer collection, released today, aims to highlight an individual's personal style. As the fastest-growing online prescription eyewear retailer, the collection marks the beginning of EyeBuyDirect's #ItsHowYouFrameIt campaign, which focuses on bright colors, limitless expression and positivity.
Vision for Life – EyeBuyDirect Announces ‘Buy 1 Give 1’ Initiative, Donating a Pair of Glasses to Needy with Every Order
eNewsChannels NEWS: -- EyeBuyDirect, the fastest growing online prescription eyewear retailer, announced today a new 'Buy 1 Give 1' Program that donates a pair of prescription glasses to someone in need worldwide for every transaction made through the online retailer. With over 2.5 billion people currently living with poor vision, the company is taking concrete action to provide solutions for those who cannot afford to buy their own eyewear.
eNewsChannels NEWS: -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching or research career in ophthalmology.
eNewsChannels NEWS: -- The fastest growing online eyewear retailer, EyeBuyDirect, has launched its new collection, Winter Whims. The collection includes 21 frames that embody the colors, textures and feeling of winter. The new Winter Whims collection is available online now. It features chocolate-brown and cinnamon-red frames that invoke the smell and tastes of the holiday season.
eNewsChannels NEWS: -- Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A Paragon Gives initiative, the scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs.
Ruling by USPTO Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formulation
eNewsChannels NEWS: (PORTLAND, Ore.,) -- Paragon BioTeck, Inc. announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.
12Page 1 of 2